Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

PerkinElmer, Inc.

NYSE

Market Cap.

14.46B

Avg. Volume

808.39K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze PerkinElmer, Inc.!

Still processing it, give me a bit more time...

PerkinElmer, Inc. News

PerkinElmer, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Diagnostics & Research
perkinelmer.com

About PerkinElmer, Inc.

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

PerkinElmer, Inc. Earnings & Revenue

PerkinElmer, Inc. Financials

Table Compare

Compare PKI metrics with:

   

Earnings & Growth

PKI

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

PKI

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

PKI

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

PKI

None

Debt Ratio

--

--

Quick Ratio

--

--

 

PerkinElmer, Inc. Income

PerkinElmer, Inc. Balance Sheet

PerkinElmer, Inc. Cash Flow

PerkinElmer, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

PerkinElmer, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.2800

Payment DateDividendFrequency
2023-08-110.07Quarterly
2023-05-120.07Quarterly
2023-02-100.07Quarterly
2022-11-110.07Quarterly
2022-08-120.07Quarterly

Historical Market Cap

Shares Outstanding

PerkinElmer, Inc. Executives

NameRole
Dr. Prahlad R. Singh Ph.D.Chief Executive Officer, Pres & Director
Mr. Joel S. GoldbergSenior Vice President of Admin., Gen. Counsel & Sec.
Mr. Daniel R. TereauSenior Vice President of Strategy & Bus. Devel.
Mr. Tajinder VohraSenior Vice President of Global Operations
Mr. Maxwell KrakowiakSenior Vice President & Chief Financial Officer
NameRoleGenderDate of BirthPay
Dr. Prahlad R. Singh Ph.D.Chief Executive Officer, Pres & Director19653.23M
Mr. Joel S. GoldbergSenior Vice President of Admin., Gen. Counsel & Sec.Male19691.29M
Mr. Daniel R. TereauSenior Vice President of Strategy & Bus. Devel.Male1968967.97K
Mr. Tajinder VohraSenior Vice President of Global OperationsMale1966927.24K
Mr. Maxwell KrakowiakSenior Vice President & Chief Financial OfficerMale1990814.58K

PerkinElmer, Inc. Insider Trades

Date15 Dec
NameGonzales Anita
RolePlease See Remarks
TransactionAcquired
TypeA-Award
Shares248
Date15 Dec
NameGonzales Anita
RolePlease See Remarks
TransactionAcquired
TypeA-Award
Shares706
Date27 Nov
NameMICHAS ALEXIS P
RoleDirector
TransactionDisposed
TypeG-Gift
Shares250
Date28 Nov
NameMICHAS ALEXIS P
RoleDirector
TransactionDisposed
TypeG-Gift
Shares230
Date15 Jun
NameGonzales Anita
RolePlease See Remarks
TransactionAcquired
TypeA-Award
Shares329
DateNameRoleTransactionTypeShares
15 DecGonzales AnitaPlease See RemarksAcquiredA-Award248
15 DecGonzales AnitaPlease See RemarksAcquiredA-Award706
27 NovMICHAS ALEXIS PDirectorDisposedG-Gift250
28 NovMICHAS ALEXIS PDirectorDisposedG-Gift230
15 JunGonzales AnitaPlease See RemarksAcquiredA-Award329

Discover More

Streamlined Academy

PerkinElmer, Inc.

NYSE

Market Cap.

14.46B

Avg. Volume

808.39K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

PerkinElmer, Inc. News

PerkinElmer, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

PerkinElmer, Inc. Earnings & Revenue

PerkinElmer, Inc. Income

PerkinElmer, Inc. Balance Sheet

PerkinElmer, Inc. Cash Flow

PerkinElmer, Inc. Financials Over Time

PerkinElmer, Inc. Executives

NameRole
Dr. Prahlad R. Singh Ph.D.Chief Executive Officer, Pres & Director
Mr. Joel S. GoldbergSenior Vice President of Admin., Gen. Counsel & Sec.
Mr. Daniel R. TereauSenior Vice President of Strategy & Bus. Devel.
Mr. Tajinder VohraSenior Vice President of Global Operations
Mr. Maxwell KrakowiakSenior Vice President & Chief Financial Officer
NameRoleGenderDate of BirthPay
Dr. Prahlad R. Singh Ph.D.Chief Executive Officer, Pres & Director19653.23M
Mr. Joel S. GoldbergSenior Vice President of Admin., Gen. Counsel & Sec.Male19691.29M
Mr. Daniel R. TereauSenior Vice President of Strategy & Bus. Devel.Male1968967.97K
Mr. Tajinder VohraSenior Vice President of Global OperationsMale1966927.24K
Mr. Maxwell KrakowiakSenior Vice President & Chief Financial OfficerMale1990814.58K

PerkinElmer, Inc. Insider Trades

Date15 Dec
NameGonzales Anita
RolePlease See Remarks
TransactionAcquired
TypeA-Award
Shares248
Date15 Dec
NameGonzales Anita
RolePlease See Remarks
TransactionAcquired
TypeA-Award
Shares706
Date27 Nov
NameMICHAS ALEXIS P
RoleDirector
TransactionDisposed
TypeG-Gift
Shares250
Date28 Nov
NameMICHAS ALEXIS P
RoleDirector
TransactionDisposed
TypeG-Gift
Shares230
Date15 Jun
NameGonzales Anita
RolePlease See Remarks
TransactionAcquired
TypeA-Award
Shares329
DateNameRoleTransactionTypeShares
15 DecGonzales AnitaPlease See RemarksAcquiredA-Award248
15 DecGonzales AnitaPlease See RemarksAcquiredA-Award706
27 NovMICHAS ALEXIS PDirectorDisposedG-Gift250
28 NovMICHAS ALEXIS PDirectorDisposedG-Gift230
15 JunGonzales AnitaPlease See RemarksAcquiredA-Award329

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
perkinelmer.com

About PerkinElmer, Inc.

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze PerkinElmer, Inc.!

Still processing it, give me a bit more time...

PerkinElmer, Inc. Financials

Table Compare

Compare PKI metrics with:

   

Earnings & Growth

PKI

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

PKI

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

PKI

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

PKI

None

Debt Ratio

--

--

Quick Ratio

--

--

 

PerkinElmer, Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.2800

Payment DateDividendFrequency
2023-08-110.07Quarterly
2023-05-120.07Quarterly
2023-02-100.07Quarterly
2022-11-110.07Quarterly
2022-08-120.07Quarterly

PerkinElmer, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More